Researchers at the Peter MacCallum Cancer Centre are pioneering the development of a new combination drug therapy to treat advanced blood cancers which has doubled survival times in pre-clinical laboratory models.
Researchers from Melbourne’s Peter MacCallum Cancer Centre have discovered a new drug which stops tumour growth and strengthens the power of chemotherapy in laboratory models of advanced oesophageal cancer, paving the way for clinical trials for people with this serious form of cancer.
A landmark clinical trial led by radiation oncologists in Australia, Canada and the United States has shown that radiation treatment of the lymph nodes in addition to the breast after breast cancer surgery can prolong the time women remain cancer-free.
The largest complete DNA analysis of ovarian cancer in the world, published overnight in Nature, has revealed unprecedented new insight into the genetic twists and turns a deadly form of the disease takes to outsmart chemotherapy, potentially changing treatment approaches for women around the world.
Associate Professor Prue Francis from the Peter MacCallum Cancer Centre has received the Medical Oncology Group of Australia’s prestigious Cancer Achievement Award for 2015, acknowledging her international leadership of practice-changing clinical trials in breast cancer.
Women with a gene mutation known to increase their cancer risk may have fewer eggs in their ovaries which may have implications for family planning, according to a study published overnight in the leading scientific journal Human Reproduction.
The Peter MacCallum Cancer Centre acknowledges the traditional
owners of the land on which our five sites are located throughout Victoria.
We recognise their strength and resilience and pay our respects
to their Elders past and present.